These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 24991785
1. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease. Kariyawasam VC, Selinger CP, Katelaris PH, Jones DB, McDonald C, Barr G, Chapman G, Colliwshaw J, Lunney PC, Middleton K, Wang RR, Huang T, Andrews J, Leong RW. Inflamm Bowel Dis; 2014 Aug; 20(8):1382-90. PubMed ID: 24991785 [Abstract] [Full Text] [Related]
2. Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification. Guo J, Chen BL, Chen ZH, Luo XP, Qiu Y, Zhang SH, Feng R, He Y, Zeng ZR, Song XM, Ben-Horin S, Mao R, Chen MH. J Gastroenterol Hepatol; 2018 Mar; 33(3):608-614. PubMed ID: 28804920 [Abstract] [Full Text] [Related]
3. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study. González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L. J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164 [Abstract] [Full Text] [Related]
4. Phenotypic features of Crohn's disease associated with failure of medical treatment. Moran GW, Dubeau MF, Kaplan GG, Yang H, Seow CH, Fedorak RN, Dieleman LA, Barkema HW, Ghosh S, Panaccione R, Alberta Inflammatory Bowel Disease Consortium. Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351 [Abstract] [Full Text] [Related]
10. Major Abdominal and Perianal Surgery in Crohn's Disease: Long-term Follow-up of Australian Patients With Crohn's Disease. Toh JWT, Wang N, Young CJ, Rickard MJFX, Keshava A, Stewart P, Kariyawasam V, Leong R, and the Sydney IBD Cohort Collaborators. Dis Colon Rectum; 2018 Jan; 61(1):67-76. PubMed ID: 29215479 [Abstract] [Full Text] [Related]
11. Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009). Chhaya V, Saxena S, Cecil E, Subramanian V, Curcin V, Majeed A, Pollok RC. Inflamm Bowel Dis; 2015 Feb; 21(2):385-91. PubMed ID: 25569740 [Abstract] [Full Text] [Related]
12. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease. Afzali A, Park CJ, Zhu K, Hu JK, Sharma P, Sinanan MN, Lee SD. Inflamm Bowel Dis; 2016 Aug; 22(8):1887-95. PubMed ID: 27057681 [Abstract] [Full Text] [Related]
13. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Lovasz BD, Szathmari M, Kiss LS, Lakatos L. Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693 [Abstract] [Full Text] [Related]
14. Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease. Qiu Y, Chen BL, Feng R, Zhang SH, He Y, Zeng ZR, Ben-Horin S, Peyrin-Biroulet L, Mao R, Chen MH. J Gastroenterol Hepatol; 2018 Mar; 33(3):664-670. PubMed ID: 28940780 [Abstract] [Full Text] [Related]
15. The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn's disease: national UK population-based study 1989-2010. Chatu S, Saxena S, Subramanian V, Curcin V, Yadegarfar G, Gunn L, Majeed A, Pollok RC. Am J Gastroenterol; 2014 Mar; 109(3):409-16. PubMed ID: 24469612 [Abstract] [Full Text] [Related]
16. Predictors of immunomodulator use as early therapy in pediatric Crohn's disease. Jacobstein DA, Mamula P, Markowitz JE, Leonard M, Baldassano RN. J Clin Gastroenterol; 2006 Feb; 40(2):145-8. PubMed ID: 16394876 [Abstract] [Full Text] [Related]
17. Thiopurine effectiveness in patients with Crohn's disease: a study of genetic and clinical predictive factors. Koifman E, Karban A, Mazor Y, Chermesh I, Waterman M, Almog R, Ben-Horin S, Eliakim R, Krivoy N, Efrati E, Chowers Y. Inflamm Bowel Dis; 2013 Jul; 19(8):1639-44. PubMed ID: 23669401 [Abstract] [Full Text] [Related]
18. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study. Huang Z, Chao K, Li M, Zhi M, Tang J, Hu P, Gao X. Inflamm Bowel Dis; 2017 Mar; 23(3):440-447. PubMed ID: 28129286 [Abstract] [Full Text] [Related]
19. Therapeutic role of methotrexate in pediatric Crohn's disease. Djurić Z, Šaranac L, Budić I, Pavlović V, Djordjević J. Bosn J Basic Med Sci; 2018 Aug 01; 18(3):211-216. PubMed ID: 29338679 [Abstract] [Full Text] [Related]
20. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery. Papay P, Reinisch W, Ho E, Gratzer C, Lissner D, Herkner H, Riss S, Dejaco C, Miehsler W, Vogelsang H, Novacek G. Am J Gastroenterol; 2010 May 01; 105(5):1158-64. PubMed ID: 20010925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]